Tourette's Syndrome Clinical Trial
Official title:
Hypersensitivity in Tourette Syndrome: An Evaluation of Perceived Intensity Versus Threshold
This study will investigate how the sensitivity to touch and smell in patients with Tourette
syndrome (TS) may differ from that of people without TS. TS is a neurological disorder that
causes people to have uncontrolled movements called "tics." A tic can also be vocal, like a
cough or bark or string of bad words. The tic is preceded by a "premonitory urge" that may
feel like an itch or pressure that builds until the tic occurs. To some patients, the tic
feels like a response to an involuntary sensation. In patients with TS, sensory information
may be processed differently than it is in people without TS. This study will compare how
strong a sensation feels in TS patients and healthy volunteers. It will also look for muscle
activity that may be responsible for the feelings in the area of the tic.
Healthy normal volunteers and people with Tourette syndrome, 18 to 65 years of age, may be
eligible for this study. Candidates are screened with a medical history and brief physical
and neurological examinations. TS patients complete a questionnaire about their tics and are
interviewed by a psychiatrist. Women who can become pregnant will have a urine pregnancy test
prior to any other procedures. Pregnant women cannot participate.
All participants undergo sensory testing for touch and smell. They are asked to distinguish
between a scented and scentless object and rate how strongly they feel the scent. Later, with
their eyes closed, they are asked to tell whether or not they are being touched, and to rate
how intensely they felt the touch.
In addition to the sensory testing, TS patients, but not normal volunteers, undergo
electromyography (EMG), a test that measures the electrical activity of muscles. For surface
EMG, small metal disks called electrodes are filled with a conductive gel and taped to the
skin. Wire EMG involves inserting a wire into a muscle using a needle. All patients have
surface EMG and those who consent to it will also have wire EMG.
OBJECTIVE:
This study will explore sensory phenomena associated with Tourette syndrome (TS). The first
part will evaluate threshold levels versus perceived intensity of tactile and olfactory
stimuli in areas reported to be hypersensitive in TS patients. The second part will use
electromyography (EMG) to seek correlation between muscle activity and the perceived
intensity of "urge" in focal areas of premonitory sensations.
STUDY POPULATION:
Twenty-six patients and 22 control subjects will be studied. Subjects can be of any race,
gender, handedness, or age from 18 to 65 years.
DESIGN:
To determine olfactory and tactile threshold, n-butanol and Von Frey hairs will be presented
in forced-choice modified method of limits paradigms. Perceived intensity will be examined
using a generalized labeled magnitude scale (gLMS), whose word values are placed on a ruler
for numerical reporting. Randomly arranged series of 7 stimuli for olfaction and touch will
be presented in 4 sets, and subjects will report a number on the gLMS that corresponds to the
intensity of each sensation. Both threshold and intensity will be measured in the peroneal
nerve territory in all subjects, and at one other variable place, which will be matched 1:1
between patients and controls. The variable spot will consist of a patient's sensory tic
site. Next, EMG activity will be measured from up to 8 muscles in the area of a sensory tic.
Patients will report when a sensory tic is occurring, and will be asked to resist the motor
tic for at least 12 seconds from that point. Total EMG activity will be measured in muscles
surrounding the sensation at 1, 4, and 7 seconds before and after the tic.
OUTCOME MEASURES:
Outcome measures include the sensory threshold values for olfaction and touch and the
reported intensity values. The outcome measures of the EMG study include the power of total
EMG activity at time points before and after a tic.
;
Status | Clinical Trial | Phase | |
---|---|---|---|
Recruiting |
NCT00965211 -
Evaluation of the HBDL Coil Transcranial Magnetic Stimulation (TMS) Device - Safety and Feasibility Study for the Treatment of Tourette Syndrome
|
N/A | |
Recruiting |
NCT00152750 -
Study of Clonidine on Sleep Architecture in Children With Tourette's Syndrome (TS) and Comorbid ADHD
|
Phase 4 | |
Terminated |
NCT00226824 -
Safety Study of Galantamine in Tic Disorders
|
Phase 4 | |
Completed |
NCT00241176 -
Open Label Trial of Aripiprazole in Children and Adolescents With Tourette's Disorder
|
Phase 4 | |
Completed |
NCT01244633 -
Ecopipam Treatment of Tourette Syndrome
|
Phase 1/Phase 2 | |
Recruiting |
NCT04805385 -
Effects of Lactobacillus Plantarum PS128 in Patients With Tourette's Syndrome
|
N/A | |
Completed |
NCT00026000 -
Brain Activation in Vocal and Motor Tics
|
N/A | |
Terminated |
NCT00001260 -
Brain Tissue Collection for Neuropathological Studies
|
||
Completed |
NCT02102698 -
Ecopipam Treatment of Tourette's Syndrome in Subjects 7-17 Years
|
Phase 2 | |
Withdrawn |
NCT02112253 -
Optimising Anterior Pallidal Deep Brain Stimulation for Tourette's Syndrome
|
Phase 1/Phase 2 | |
Withdrawn |
NCT01133353 -
A Study of the Effectiveness and Safety of Tetrabenazine MR in Pediatric Subjects With Tourette's Syndrome
|
Phase 2 | |
Completed |
NCT02205918 -
Brain-Behavior Interactions in Tic Suppression
|
||
Terminated |
NCT00282139 -
Aripiprazole in the Treatment of Tourette's Syndrome
|
N/A | |
Completed |
NCT03042507 -
Psychosocial Intervention for Young Children With Chronic Tics
|
N/A | |
Completed |
NCT01019343 -
Physiological Investigations of Movement Disorders
|
N/A | |
Completed |
NCT02619084 -
Subthalamic Stimulation in Tourette's Syndrome
|
Phase 2 | |
Withdrawn |
NCT01475383 -
Study Evaluating The Safety And Efficacy Of PF-03654746 In Adult Subjects With Tourette's Syndrome
|
Phase 2 | |
Not yet recruiting |
NCT06361004 -
Exploring DBS Efficacy in Treatment-refractory Tourette's Syndrome
|
N/A | |
Completed |
NCT00139308 -
High Frequency Stimulation of the GPi or Thalamus in Tourette's Syndrome
|
Phase 1 |